SCHEMBL19861866

SCHEMBL19861866

CN(C)CCC[Si](C)(C)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
TSHR P16473 1/20 0.45
DNM1 Q05193 4/20 0.38
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 3/20 0.33
HRH4 Q9H3N8 2/20 0.33
CYP1A2 P05177 1/20 0.33
HRH2 P25021 1/20 0.33
HSD17B10 Q99714 1/20 0.32
CA2 P00918 3/20 0.32
CA12 O43570 2/20 0.32
CA9 Q16790 2/20 0.32
CA3 P07451 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
CA5A P35218 1/20 0.32
CA7 P43166 1/20 0.32
CA14 Q9ULX7 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
CA1 P00915 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21741888 0.83 ALDH1A1 (0.45) ALDH1A1TSHRDNM1MAPTTDP1
SCHEMBL17739561 0.80 ALDH1A1 (0.47) ALDH1A1TSHRDNM1MAPTTDP1
Hydrochloric Acid SCHEMBL31505252 0.78 ALDH1A1 (0.45) ALDH1A1TSHRDNM1MAPTTDP1
Hydrochloric Acid SCHEMBL31505254 0.78 ALDH1A1 (0.45) ALDH1A1TSHRDNM1MAPTTDP1
Hydrochloric Acid SCHEMBL31505253 0.78 ALDH1A1 (0.45) ALDH1A1TSHRDNM1MAPTTDP1
SCHEMBL13171447 0.77 ALDH1A1 (0.39) ALDH1A1TSHRDNM1MAPTTDP1
SCHEMBL8207425 0.77 ALDH1A1 (0.50) ALDH1A1TSHRDNM1MAPTTDP1
SCHEMBL8928256 0.77 ALDH1A1 (0.50) ALDH1A1TSHRDNM1MAPTTDP1
SCHEMBL12196156 0.76
SCHEMBL8762300 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023223803-A1 METHOD FOR PRODUCING AQUEOUS SOLUTION OF PURIFIED AMINOSILANOL COMPOUND AND AMINOSILOXANE COMPOUND, AND COMPOSITION FOR ETCHING 信越化学工業株式会社 2023-11-23 WO disclosed
US-20210060170-A1 PHOTODYNAMIC THERAPY COMPOSITION CASE WESTERN RESERVE UNIVERSITY 2021-03-04 US disclosed
US-10709794-B2 Photodynamic therapy composition CASE WESTERN RESERVE UNIVERSITY (US) 2020-07-14 US disclosed
US-9889199-B2 PSMA ligands and uses thereof CASE WESTERN RESERVE UNIVERSITY (US) 2018-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10709794-B2 Photodynamic therapy composition FAP, PPIC, CD47 ALDH1A1 439/4885TSHR 4388/4885DNM1 925/4885
US-20210060170-A1 PHOTODYNAMIC THERAPY COMPOSITION PSMA1, PSMA7, FOLH1 ALDH1A1 396/4885TSHR 4435/4885DNM1 3035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.